Hackensack University Medical Center Offering Minimally Invasive Zephyr Endobronchial Valve Treatment for Patients with Severe Emphysema

What You Need To Know

• Hackensack Meridian Hackensack University Medical Center is now offering Zephyr® Endobronchial Valves, a new, minimally invasive treatment for patients with severe emphysema.
• The valve — which was the first endobronchial valve to receive FDA approval in 2018 for patients with heterogenous and homogenous emphysema — helps patients breathe more easily by releasing the trapped air in the diseased part of the lung.
• Zephyr Endobronchial Valves are placed while the patient is under conscious sedation or anesthesia  — watch in this video. 
• The Zephyr Valve treatment is included in severe COPD and emphysema treatment recommendations issued by leading health organizations worldwide.